Tirzepatide 10MG

One peptide, two receptors: GIP and GLP-1. 10 mg per vial.

Tirzepatide (LY3298176) is a synthetic 39-residue peptide described in the literature as a dual agonist at the GIP and GLP-1 receptors. It carries two non-coded Aib residues and a C20 fatty diacid attached to the lysine at position 20 through a γ-glutamate and linker. Molecular formula C225H348N48O68, molecular weight 4813.5 g/mol, CAS 2023788-19-2. Each vial holds 10 mg of lyophilised powder, sealed and stored at −20°C.

For laboratory research use only. Not for human or animal use.

Compound

Tirzepatide

Also known as

LY3298176

Class

Dual receptor agonist

Contents per vial

10 mg

Form

Lyophilised powder

Sequence

39-residue peptide with Aib2, Aib13 and a lipidated Lys20 (C20 diacid via γGlu–2×OEG linker), C-terminal amide

Molecular formula

C₂₂₅H₃₄₈N₄₈O₆₈

Molecular weight

4813.5 g/mol

CAS number

2023788-19-2

Purity (HPLC)

≥99%

Storage

−20°C, sealed, away from light

Store sealed vials at −20°C, away from light. Vials are lyophilised and sealed under nitrogen before storage, and stay frozen until your order is packed. A safety data sheet is available on request.

Dispatched from within Australia by tracked post. Orders paid before 2pm Melbourne time on a business day leave the same day. Express tracked shipping is free on orders over $350.00. See Shipping & payment for delivery times and fees.